Clinical Trial

Kebele Elimination of Trachoma for Ocular Health

Study acronym: KETFO
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2017-11-03; most recent amendment 2025-10-21.
Status change: Recruiting → Active, Not Recruiting 2025-10-21
Status change: Not Yet Recruiting → Recruiting 2022-02-22
Trial Details
NCT Number NCT03335072
Lead Sponsor University of California, San Francisco
Collaborators: National Eye Institute (NEI), Eyu-Ethiopia, Bahir Dar University
Conditions Trachoma
Enrollment 320,000 participants
Start Date 2022-02-07
Primary Completion 2027-03-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-23